MINUTOLO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 6.233
EU - Europa 4.636
AS - Asia 1.168
SA - Sud America 36
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 12.101
Nazione #
US - Stati Uniti d'America 6.215
IE - Irlanda 1.588
UA - Ucraina 812
GB - Regno Unito 628
IT - Italia 494
CN - Cina 448
DE - Germania 371
SG - Singapore 371
SE - Svezia 214
TR - Turchia 212
FI - Finlandia 210
GR - Grecia 127
KR - Corea 62
FR - Francia 48
BE - Belgio 38
RU - Federazione Russa 36
CZ - Repubblica Ceca 23
BR - Brasile 19
HK - Hong Kong 17
CA - Canada 13
IR - Iran 12
AT - Austria 11
NL - Olanda 11
PH - Filippine 11
ES - Italia 9
ID - Indonesia 7
EU - Europa 6
IN - India 5
JP - Giappone 5
SC - Seychelles 5
CL - Cile 4
CO - Colombia 4
AR - Argentina 3
BD - Bangladesh 3
KZ - Kazakistan 3
MK - Macedonia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TW - Taiwan 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
EG - Egitto 2
HU - Ungheria 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
RW - Ruanda 2
TH - Thailandia 2
UG - Uganda 2
VN - Vietnam 2
AO - Angola 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
UY - Uruguay 1
VE - Venezuela 1
Totale 12.101
Città #
Dublin 1.587
Jacksonville 1.239
Santa Clara 946
Chandler 896
Chicago 466
Princeton 242
Wilmington 224
Singapore 215
Medford 207
Roxbury 150
Boardman 145
Ann Arbor 139
Falls Church 133
San Mateo 121
Woodbridge 96
Beijing 95
Naples 70
Nanjing 58
Caserta 54
Bremen 53
Seoul 53
Istanbul 51
Des Moines 50
New York 49
Cambridge 39
Brussels 38
Jinan 37
Saint Petersburg 32
Houston 29
Mountain View 28
Norwalk 26
Munich 25
Napoli 25
Shenyang 23
Brno 22
Zhengzhou 21
Ashburn 19
Milan 17
Hong Kong 16
Ercolano 13
Guangzhou 13
Helsinki 13
Los Angeles 13
Ningbo 13
Rome 13
Auburn Hills 12
Tianjin 12
Hangzhou 11
Nanchang 11
Shanghai 11
Taizhou 11
Nuremberg 10
Seattle 10
Zanjan 10
Changsha 9
Redwood City 9
Taiyuan 9
Düsseldorf 8
Hebei 8
Jiaxing 8
Kunming 8
Vienna 8
Florence 7
Lanzhou 7
Lappeenranta 7
Ottawa 7
London 6
Aversa 5
Fairfield 5
Frankfurt am Main 5
Haikou 5
Melito di Napoli 5
Bologna 4
Cantù 4
Cattolica 4
Groningen 4
Torino 4
Amsterdam 3
Catania 3
Dallas 3
Dearborn 3
Edinburgh 3
Hanover 3
Madrid 3
Modena 3
North Bergen 3
Padova 3
Potenza 3
Prilep 3
Quezon City 3
Rio de Janeiro 3
Sacramento 3
Santiago 3
Turin 3
Verona 3
Aci Catena 2
Almaty 2
Atlanta 2
Banda Aceh 2
Bekasi 2
Totale 8.122
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 773
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 125
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 118
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 96
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 83
Empagliflozin in Patients with Chronic Kidney Disease 82
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 77
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 76
[Anti-diabetics and chronic kidney disease] 76
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 75
Daily nutrient intake in hemodialysis. 74
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 73
Amino acid loss during dialysis treatment 73
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 71
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 71
Epidemiology of chronic kidney disease in Italy: the CARHES study 70
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 70
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 69
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 69
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 68
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 66
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 65
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 64
Management of hypertension in chronic kidney disease: the Italian multicenter study. 63
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 63
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 63
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 62
Effetto antiproteinurico di ACE inibitori e Losartan e polimorfismo del gene dell’ACE 62
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 61
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 61
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 61
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 61
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 61
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 60
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 60
Management of hypertension in chronic kidney disease 60
Disfunzione renale nell’anziano: processo fisiologico o malattia? 60
[Iron deficiency in ND-CKD: from diagnosis to treatment] 60
Management of hypertension in chronic kidney disease: the italian multicentric study 59
Heart Failure in chronic kidney disease: from epidemiology to therapy. 59
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 59
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 58
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 58
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 58
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 58
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 58
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 58
Epidemiology of CKD Regression in Patients under Nephrology Care 58
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 58
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 57
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 57
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 57
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up 57
[Epidemiology and prognosis of chronic kidney disease in Italy] 57
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 56
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 56
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 56
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 56
CALCOLOSI RENALE 56
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 56
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 56
AISF position paper on HCV in immunocompromised patients 56
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 55
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 55
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 55
Manuale di Terapia delle Malattie Renali 55
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 55
Stability of target hemoglobin levels during the first year of epoetin treatment in CKD patients. 54
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 54
[Hyperuricaemia and Chronic Kidney Disease] 54
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 53
Effect of a low- versus moderate-protein diet on progression of CKD: Follow-up of a randomized controlled trial 53
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes 53
Epidemiology of chronic kidney disease in Italy 53
Effects of age on hypertensive status in patients with chronic kidney disease 52
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 52
Patogenesi del rebound post-dialitico del fosforo 52
Resistant hypertension in nondialysis chronic kidney disease. 52
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 52
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 51
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 51
Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial 51
Hypertension in patients on hemodialysis: the role of salt intake. 51
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 51
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 51
Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. 51
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 51
Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter? 50
Clinical policies on the management of chronic kidney disease patients in Italy 50
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 50
Diagnostic role of ambulatory blood pressure monitoring in non-dialysis CKD patients 50
Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings 50
Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial 49
Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes 49
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 49
Pro: Thresholds to define chronic kidney disease should not be age-dependent 49
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 49
Gestione dei fattori di rischio cardiovascolare (CV) nella nefropatia diabetica tipo 2 (ND): analisi comparativa tra nefrologia, diabetologia e medicina generale 49
Prevention of diabetic nephropathy: from bench to bedside 49
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. 49
Totale 6.735
Categoria #
all - tutte 56.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020489 0 0 0 0 0 0 245 22 118 46 47 11
2020/20211.807 171 14 218 134 349 8 234 197 17 243 173 49
2021/20221.760 154 42 42 72 523 15 36 51 64 144 158 459
2022/20233.530 315 108 313 287 327 289 9 211 1.496 36 62 77
2023/20241.205 116 44 53 113 447 63 29 20 17 23 84 196
2024/20251.494 12 72 59 121 648 577 5 0 0 0 0 0
Totale 12.462